Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From 2 Phase 3, Randomized, Double-blind Studies
Papp
K,
Szepietowski
JC,
Kircik
L. J Am Acad Dermatol. 2021;85(4):863–872
Source: PEDIATRICS - Category: Pediatrics Source Type: research